Quantcast

Latest Central nervous system Stories

2014-07-23 08:31:01

- Brivaracetam is the newest investigational medicine to emerge from UCB's rich late-stage pipeline BRUSSELS, July 23, 2014 /PRNewswire/ -- regulated information -- UCB today announced an important advance in its research and development pipeline with positive topline results from the latest Phase 3 study with brivaracetam. This study was designed to evaluate the efficacy and safety of brivaracetam (100 and 200 mg/day, without titration) compared to placebo, as adjunctive treatment in adult...

2014-07-15 16:27:31

LONDON, July 15, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Epilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with Novel Mechanisms of Action Signal a Shift in Treatment Patternshttps://www.reportbuyer.com/product/2052297/Epilepsy-Therapeutics-in-Major-Developed-Markets-to-2019---New-AEDs-with-Novel-Mechanisms-of-Action-Signal-a-Shift-in-Treatment-Patterns.htmlEpilepsy Therapeutics in Major Developed Markets to 2019 - New AEDs with...

2014-07-15 08:28:37

WAYNE, Pa. and PORTO, Portugal, July 15, 2014 /PRNewswire/ -- BIAL, a research based international pharmaceutical company, and moksha8, a leading specialty pharmaceutical company in Latin America, announced today an exclusive license for the commercialization of eslicarbazepine acetate (Zebinix® / (Exalief®) in Brazil and Mexico for the treatment of epilepsy. Epilepsy is one of the most common neurological diseases, affecting 70 million worldwide and up to 5 million people in Latin America...

2014-07-05 23:01:15

North American Neurostimulation/Neuromodulation market report estimates the market for different neuromodulation techniques as well as geographic analysis. http://www.micromarketmonitor.com/market/north-america-neurostimulation-neuromodulation-9466950772.html (PRWEB) July 05, 2014 The global neuromodulation market is estimated to be $4503.9 million in 2013, and is expected to reach $7810.4 million by 2018 at a CAGR of 11.6%. Amongst one of the advanced technologies, neuromodulation treats...

2014-06-30 08:31:21

First Branded Product in CNS Portfolio Now Available MAPLE GROVE, Minn., June 30, 2014 /PRNewswire/ -- Upsher-Smith Laboratories, Inc. (Upsher-Smith), today announced that Qudexy(TM) XR (topiramate) extended-release capsules is now available to patients in the United States. Qudexy(TM) XR is a once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile. It was approved by the U.S. Food and Drug Administration in March 2014...

2014-06-25 10:19:51

University of California - Irvine Noninvasive diagnostic technique could greatly enhance use of preventive therapies A newly discovered biomarker – visible in brain scans for hours after febrile seizures – predicts which individuals will subsequently develop epilepsy, according to UC Irvine researchers. This diagnostic ability could lead to improved use of preventive therapies for the disorder. A team led by Dr. Tallie Z. Baram found that rats exhibiting this novel signal in...

2014-06-17 08:26:35

Recently FDA Approved Qudexy(TM) XR Offers a New Treatment Option for Managing Specific Seizure Types MAPLE GROVE, Minn., June 17, 2014 /PRNewswire/ -- Results from Upsher-Smith Laboratories, Inc.'s, Phase 3 study of USL255, Qudexy(TM) XR (topiramate) extended-release capsules, a proprietary, once-daily, broad-spectrum antiepileptic drug specifically engineered to deliver a smooth pharmacokinetic (PK) profile, were published in the June issue of Epilepsia, a leading, authoritative...

2014-06-13 12:23:30

Pre-Game Activities Honor Local Epilepsy Awareness Ambassador Families NEW YORK, June 13, 2014 /PRNewswire-iReach/ -- The Epilepsy Foundation of Metropolitan New York will host its 2(nd) Annual Epilepsy Awareness Day at Citi Field during a matchup between the New York Mets and the San Diego Padres at Citi Field on Father's Day, Sunday, June 15, 2014. The event will feature several exhibits and family activities designed to help raise public awareness about epilepsy and to celebrate...

2014-06-03 12:39:14

Epilepsy Organizations, Scientists, Bereaved Parents & Epilepsy Patients to Join Forces MINNEAPOLIS, June 3, 2014 /PRNewswire-USNewswire/ -- When 4-year-old Henry Lapham was diagnosed with epilepsy, his parents Gardiner and Nicholas Lapham were devastated, but certain that with the proper care and medication, everything would be fine. Nothing could be further from the truth. A mere five weeks after Henry's diagnosis, a seizure took his life. He died from a phenomenon called Sudden...

2014-05-27 23:13:00

The Notus Sports Golf Challenge at Birdwood Golf Course on June 19 will raise funds for the Blue Ridge Chapter of the National Multiple Sclerosis Society. Proceeds will be earmarked for fitness programs to help local patients with MS improve their health and ease the progression of the disease. Charlottesville, VA (PRWEB) May 27, 2014 Notus Sports and Event Management Group recently announced the first tournament in a series of charity golf tournaments it will run: the Notus Sports...


Word of the Day
glogg
  • Scandinavian punch made of claret and aquavit with spices and raisins and orange peel and sugar.
This word comes from the Swedish 'glogg,' which is an alteration of 'glodgat,' mulled (wine).
Related